https://regulatorynews.com/biocon-pebrilzo-pertuzumab-biosimilar-chmp Regulatory News en 2026-09-22T05:59:25-04:00 CHMP Clears First mAb Biosimilar Under New EU Path https://regulatorynews.com/fda-nonclinical-testing-terminology-rule Regulatory News en 2026-09-22T05:59:25-04:00 FDA Swaps 'Animal Testing' for 'Nonclinical' in Rules https://regulatorynews.com/mhra-wireless-ctg-monitor-rf-interference Regulatory News en 2026-09-22T05:59:25-04:00 MHRA Curbs Wireless Fetal Monitor Signal Mix-Ups https://regulatorynews.com/circle-pharma-series-e-cid165-financing Regulatory News en 2026-09-21T09:37:33-04:00 Circle Pharma Raises $92.5M Series E for Cancer Drug https://regulatorynews.com/koning-health-breast-ct-tga-approval Regulatory News en 2026-09-21T09:37:33-04:00 Koning Health Wins TGA Approval for Breast CT System https://regulatorynews.com/sk-biopharmaceuticals-cenobamate-japan-approval Regulatory News en 2026-09-21T09:37:33-04:00 SK Biopharmaceuticals Completes Japan Epilepsy Approval https://regulatorynews.com/corcept-lifyorli-chmp-ovarian-cancer Regulatory News en 2026-09-21T05:58:17-04:00 CHMP Backs Corcept's Lifyorli for Ovarian Cancer https://regulatorynews.com/puretech-lyt200-mds-fast-track Regulatory News en 2026-09-21T05:58:17-04:00 FDA Grants Fast Track to PureTech's MDS Antibody https://regulatorynews.com/cyllene-eg110a-rmat-designation Regulatory News en 2026-09-20T09:33:47-04:00 Cyllene Wins FDA RMAT Status for Bladder Gene Therapy https://regulatorynews.com/sling-linsitinib-series-c-financing Regulatory News en 2026-09-20T09:33:47-04:00 Sling Nets $123M to Push Eye Drug Into Phase 3